丙基膦酸单苯酯 | 53621-79-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 丙基膦酸单苯酯
• 英文名称: O-Phenylhydrogenpropylphosphonat
• 英文别名: Phosphonic acid, propyl-, phenyl ester；phenoxy(propyl)phosphinic acid
• CAS: 53621-79-7
• 化学式: C₉H₁₃O₃P
• 分子量: 200.174
• InChiKey: CRKIOGSAUZSJOT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2931900090

文献信息

• ANTIVIRAL COMPOUNDS
  申请人：VIROVAX LLC

  公开号：US20210238210A1

  公开（公告）日：2021-08-05

  A compound can include the structure of Formula 1, derivative thereof, prodrug thereof, salt thereof, stereoisomer thereof, tautomer thereof, polymorph thereof, or solvate thereof, or having any chirality at any chiral center: R 1 includes a hydrogen or a substituent; R 2 includes a hydroxyl, hydroxyl-forming prodrug, or hydroxyl-leaving chemical moiety; R 3 includes a halogen; and R 4 includes a heterocycle. The compound can be an antiviral compound used in antiviral therapies.

  一个化合物可以包含公式1的结构、其衍生物、前药、盐、立体异构体、互变异构体、多晶型或溶剂化物，或者在任何手性中心具有任何手性：R1包括氢或取代基；R2包括羟基、形成羟基的前药或离开羟基的化学基团；R3包括卤素；R4包括杂环。该化合物可以是一种用于抗病毒治疗的抗病毒化合物。
• Method for producing allyl compound, and ether or ester compound produced thereby
  申请人：MITSUBISHI CHEMICAL CORPORATION

  公开号：US20040147757A1

  公开（公告）日：2004-07-29

  A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with an oxygen nucleophilic agent in the presence of a catalyst containing at least one transition metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and a multidentate phosphite compound.

  一种生产具有与烯丙基起始物质化合物不同的组成式的烯丙基化合物的方法，包括在存在至少一种含有从周期表第8组到第10组的过渡金属属于的过渡金属的过渡金属化合物和多齿膦酸酯化合物的催化剂的情况下，将烯丙基起始物质化合物与氧亲核试剂反应。
• Method for producing allyl compound
  申请人：MITSUBISHI CHEMICAL CORPORATION

  公开号：US20040092777A1

  公开（公告）日：2004-05-13

  A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with an oxygen nucleophilic agent having a structure different from that of the allyl starting material compound in the presence of a catalyst containing at least one transition metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and a monodentate phosphite compound having a structure of the following formula (1): P(OR 1 )(OR 2 )(OR 3 )   (1) wherein R 1 , R 2 and R 3 are respectively independently an alkyl group which may have a substituent, carbon chains of R 1 , R 2 and R 3 may have at least one carbon-carbon double bond or triple bond, and at least two optional groups of R 1 , R 2 and R 3 may bond to each other to form at least one cyclic structure.

  一种制备具有与烯丙基起始材料化合物不同组成式的烯丙基化合物的方法，包括在至少包含选择自周期表8至10族过渡金属的过渡金属化合物和具有以下式（1）结构的单齿磷酸酯化合物催化剂存在下，将烯丙基起始材料化合物与具有不同于烯丙基起始材料化合物的结构的氧亲核试剂反应，其中式（1）中，R1、R2和R3分别独立地是可以具有取代基的烷基，R1、R2和R3的碳链可以具有至少一个碳-碳双键或三键，并且R1、R2和R3的至少两个可选基团可以结合形成至少一个环状结构。
• Method for producing allyl compound, and allyl compound produced thereby
  申请人：Takai Masaki

  公开号：US20050075518A1

  公开（公告）日：2005-04-07

  A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with a nucleophilic agent in the presence of a catalyst containing at least one transitional metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and at least one bidentate coordinated phosphite compound selected from the group consisting of compounds having structures of the following formulae (I) to (III): wherein A 1 to A 3 are respectively independently a diarylene group having a branched alkyl group at the ortho-position, R 1 to R 6 are respectively independently an alkyl group which may have a substituent or an aryl group which may have a substituent (including a heterocyclic compound forming an aromatic 6π electron cloud on the upper and lower sides of the ring, hereinafter the same), and Z 1 to Z 3 are respectively independently an alkylene group which may have a substituent, an arylene group which may have a substituent, an alkylene-arylene group which may have a substituent or a diarylene group which may have a substituent.

  一种制备具有不同于烯丙基起始材料化合物的组成式的烯丙基化合物的方法，包括在催化剂的存在下，将烯丙基起始材料化合物与亲核试剂反应，所述催化剂包含至少一种过渡金属化合物，所述过渡金属选自周期表8到10组的过渡金属，并且至少一种双齿配位膦酸酯化合物，所述化合物具有以下式(I)到(III)中的结构，其中A1到A3分别独立地是具有支链烷基的二芳基基团，R1到R6分别独立地是可以具有取代基的烷基基团或可以具有取代基的芳基基团（包括在环上形成芳香6π电子云的杂环化合物，在此以后相同），Z1到Z3分别独立地是可以具有取代基的烷基，可以具有取代基的芳基，可以具有取代基的烷基-芳基基团或可以具有取代基的二芳基基团。
• PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS
  申请人：Crawford Kenneth R.

  公开号：US20110065631A1

  公开（公告）日：2011-03-17

  A process for the synthesis of bisfuran intermediates of formula (0) useful for preparing antiviral HIV protease inhibitor compounds is hereby disclosed. Furthermore disclosed is a HIV protease inhibitor of formula (IV) as well as various intermediates thereof.

  本发明公开了一种用于合成式（0）的双呋喃中间体的过程，该中间体对于制备抗病毒HIV蛋白酶抑制剂化合物非常有用。此外，本发明还公开了式（IV）的HIV蛋白酶抑制剂以及其各种中间体。